N1-(2 tetrahydrofuryl)-5-fluorouracil (FT-207) in the postoperative adjuvant chemotherapy of gastric cancer. Delivery of a fat-emulsified agent to the lymph

The influence of fat emulsification of N1-(2-tetrahydrofuryl)-5-fluorouracil (FT-207) on lymphatic transport was studied in seven postoperative gastric cancer patients. The water-in-oil-type of emulsion of FT-207 (FT-w/o), the oil-in-water-type emulsion of FT-207 (FT-o/w) and an enteric-coated granu...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Cancer Ročník 57; číslo 4; s. 693
Hlavní autori: Hanaue, H, Kurosawa, T, Kitano, Y, Miyakawa, S, Horie, F, Nemoto, A, Shikata, J
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States 15.02.1986
Predmet:
Adult
Aged
Antineoplastic Agents - administration & dosage
Antineoplastic Agents - metabolism
Combined Modality Therapy
Fat Emulsions, Intravenous - metabolism
Fluorouracil - metabolism
Humans
Lymph - metabolism
Male
Middle Aged
Postoperative Care
Stomach Neoplasms - drug therapy
Stomach Neoplasms - metabolism
Stomach Neoplasms - surgery
Tegafur - administration & dosage
Tegafur - metabolism
Thoracic Duct - metabolism
ISSN:0008-543X
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract The influence of fat emulsification of N1-(2-tetrahydrofuryl)-5-fluorouracil (FT-207) on lymphatic transport was studied in seven postoperative gastric cancer patients. The water-in-oil-type of emulsion of FT-207 (FT-w/o), the oil-in-water-type emulsion of FT-207 (FT-o/w) and an enteric-coated granule of FT-207 (FT-G) each in 1-g doses, calculated in terms of FT-207, were administered orally. Lymph from a thoracic duct fistula, prepared in advance, and from the blood of a peripheral vein was collected simultaneously along a time course after administration to measure the concentrations of FT-207 and 5-fluorouracil (5-FU). For FT-w/o, FT-207, and 5-FU, concentrations were significantly higher, both in the lymph and in the blood, than those for FT-G and FT-o/w. However, no significant differences in FT-207 and 5-FU concentrations were observed between FT-o/w and FT-G. It was concluded that FT-w/o can be useful as an adjuvant chemotherapeutic drug in the postoperative treatment of gastric cancer.
AbstractList The influence of fat emulsification of N1-(2-tetrahydrofuryl)-5-fluorouracil (FT-207) on lymphatic transport was studied in seven postoperative gastric cancer patients. The water-in-oil-type of emulsion of FT-207 (FT-w/o), the oil-in-water-type emulsion of FT-207 (FT-o/w) and an enteric-coated granule of FT-207 (FT-G) each in 1-g doses, calculated in terms of FT-207, were administered orally. Lymph from a thoracic duct fistula, prepared in advance, and from the blood of a peripheral vein was collected simultaneously along a time course after administration to measure the concentrations of FT-207 and 5-fluorouracil (5-FU). For FT-w/o, FT-207, and 5-FU, concentrations were significantly higher, both in the lymph and in the blood, than those for FT-G and FT-o/w. However, no significant differences in FT-207 and 5-FU concentrations were observed between FT-o/w and FT-G. It was concluded that FT-w/o can be useful as an adjuvant chemotherapeutic drug in the postoperative treatment of gastric cancer.The influence of fat emulsification of N1-(2-tetrahydrofuryl)-5-fluorouracil (FT-207) on lymphatic transport was studied in seven postoperative gastric cancer patients. The water-in-oil-type of emulsion of FT-207 (FT-w/o), the oil-in-water-type emulsion of FT-207 (FT-o/w) and an enteric-coated granule of FT-207 (FT-G) each in 1-g doses, calculated in terms of FT-207, were administered orally. Lymph from a thoracic duct fistula, prepared in advance, and from the blood of a peripheral vein was collected simultaneously along a time course after administration to measure the concentrations of FT-207 and 5-fluorouracil (5-FU). For FT-w/o, FT-207, and 5-FU, concentrations were significantly higher, both in the lymph and in the blood, than those for FT-G and FT-o/w. However, no significant differences in FT-207 and 5-FU concentrations were observed between FT-o/w and FT-G. It was concluded that FT-w/o can be useful as an adjuvant chemotherapeutic drug in the postoperative treatment of gastric cancer.
The influence of fat emulsification of N1-(2-tetrahydrofuryl)-5-fluorouracil (FT-207) on lymphatic transport was studied in seven postoperative gastric cancer patients. The water-in-oil-type of emulsion of FT-207 (FT-w/o), the oil-in-water-type emulsion of FT-207 (FT-o/w) and an enteric-coated granule of FT-207 (FT-G) each in 1-g doses, calculated in terms of FT-207, were administered orally. Lymph from a thoracic duct fistula, prepared in advance, and from the blood of a peripheral vein was collected simultaneously along a time course after administration to measure the concentrations of FT-207 and 5-fluorouracil (5-FU). For FT-w/o, FT-207, and 5-FU, concentrations were significantly higher, both in the lymph and in the blood, than those for FT-G and FT-o/w. However, no significant differences in FT-207 and 5-FU concentrations were observed between FT-o/w and FT-G. It was concluded that FT-w/o can be useful as an adjuvant chemotherapeutic drug in the postoperative treatment of gastric cancer.
Author Miyakawa, S
Shikata, J
Kurosawa, T
Kitano, Y
Hanaue, H
Horie, F
Nemoto, A
Author_xml – sequence: 1
  givenname: H
  surname: Hanaue
  fullname: Hanaue, H
– sequence: 2
  givenname: T
  surname: Kurosawa
  fullname: Kurosawa, T
– sequence: 3
  givenname: Y
  surname: Kitano
  fullname: Kitano, Y
– sequence: 4
  givenname: S
  surname: Miyakawa
  fullname: Miyakawa, S
– sequence: 5
  givenname: F
  surname: Horie
  fullname: Horie, F
– sequence: 6
  givenname: A
  surname: Nemoto
  fullname: Nemoto, A
– sequence: 7
  givenname: J
  surname: Shikata
  fullname: Shikata, J
BackLink https://www.ncbi.nlm.nih.gov/pubmed/3080217$$D View this record in MEDLINE/PubMed
BookMark eNotkMFq3DAQQHVISZO0n1DQqewetBnJlmVvS2HrJG0gJFBS6G0Zy6Osg225shzwv_Rj66Z7Gob3eANzzk563xNjXyVsJIC6lFAYATJVK1nkGSip19ps089ZkWy3u9srUd6XP1SuQBtIQX1JNrApHz4psTthZwCQC50mv96y83F8XlajdHLKThPIl5Q5Y3_upVgpHikGPMx18G4Kc7sWWrh28sFPAW3T8tXNo1Bg1rzpeTwQH_wY_UABY_NCHOvn6QX7yO2BOr_wgMPMveNPOMbQWG6xtxQ2_IraxQ-vDLnDKKib2rFxDdUcn2hJRP96oJ274fCOvXHYjvT-OC_Yz5vrx_K7uHv4dlvu7oTVoJWQmTXOVTJBTAllolSS145AaUwL61KAGm1NqdO2SrJKWZOZXNsFqbr651-wj_-7Q_C_JxrjvmtGS22LPflp3JssKyRIs4gfjuJUdVTvh9B0GOb98Z3qL4v0gis
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1002/1097-0142(19860215)57:4<693::AID-CNCR2820570402>3.0.CO;2-A
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
ExternalDocumentID 3080217
Genre Journal Article
GroupedDBID ---
-~X
.GA
.GJ
05W
0R~
1CY
1L6
1OC
24P
29B
33P
3SF
3WU
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52T
52U
52V
52W
52X
53G
5GY
66C
6J9
6P2
6PF
702
7PT
8-0
8-1
85S
8UM
930
AAESR
AAHHS
AAONW
AARRQ
AAWTL
ABCQN
ABEML
ABHFT
ABIVO
ABJNI
ABLJU
ABOCM
ABPPZ
ACGFO
ACGFS
ACNCT
ACPRK
ACSCC
ACXQS
ADBBV
ADKYN
ADOZA
ADZMN
ADZOD
AENEX
AEUQT
AFBPY
AFFPM
AFRAH
AGNAY
AI.
AIAGR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
AMBMR
ATUGU
AZBYB
BAFTC
BAWUL
BY8
C45
CGR
CS3
CUY
CVF
D-6
D-7
D-E
D-F
DIK
DR2
DRFUL
E3Z
EBS
ECM
EIF
EJD
F04
F5P
FD6
GNP
GODZA
GX1
H.X
HBH
HHY
HHZ
HZ~
IH2
IX1
J0M
J5H
JPC
KQQ
KZ1
L7B
LATKE
LC2
LC3
LITHE
LOXES
LSO
LUTES
LW6
MK4
MRFUL
MRMAN
MSFUL
MSSTM
N04
N05
N9A
NEJ
NF~
NNB
NPM
O66
O9-
OHT
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
Q.N
QRW
RWI
RX1
SJN
SUPJJ
TEORI
UDS
UHB
V8K
V9Y
VH1
VXZ
W8V
W99
WBKPD
WH7
WIH
WIJ
WIK
WIN
WJL
WVDHM
WXI
XV2
Z0Y
ZGI
ZXP
~WT
7X8
AAMMB
AEFGJ
AEYWJ
AGXDD
AIDQK
AIDYY
ID FETCH-LOGICAL-c5052-16c7ffb13aa4ea132238dfe025a49cf400dacde4f5cb36b2c76785c9cf2dba132
IEDL.DBID 7X8
ISSN 0008-543X
IngestDate Sun Sep 28 14:08:37 EDT 2025
Wed Feb 19 02:32:56 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5052-16c7ffb13aa4ea132238dfe025a49cf400dacde4f5cb36b2c76785c9cf2dba132
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%2819860215%2957%3A4%3C693%3A%3AAID-CNCR2820570402%3E3.0.CO%3B2-A
PMID 3080217
PQID 76691017
PQPubID 23479
ParticipantIDs proquest_miscellaneous_76691017
pubmed_primary_3080217
PublicationCentury 1900
PublicationDate 15 February 1986
PublicationDateYYYYMMDD 1986-02-15
PublicationDate_xml – month: 02
  year: 1986
  text: 15 February 1986
  day: 15
PublicationDecade 1980
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Cancer
PublicationTitleAlternate Cancer
PublicationYear 1986
SSID ssj0007253
Score 1.3332683
Snippet The influence of fat emulsification of N1-(2-tetrahydrofuryl)-5-fluorouracil (FT-207) on lymphatic transport was studied in seven postoperative gastric cancer...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 693
SubjectTerms Adult
Aged
Antineoplastic Agents - administration & dosage
Antineoplastic Agents - metabolism
Combined Modality Therapy
Fat Emulsions, Intravenous - metabolism
Fluorouracil - metabolism
Humans
Lymph - metabolism
Male
Middle Aged
Postoperative Care
Stomach Neoplasms - drug therapy
Stomach Neoplasms - metabolism
Stomach Neoplasms - surgery
Tegafur - administration & dosage
Tegafur - metabolism
Thoracic Duct - metabolism
Title N1-(2 tetrahydrofuryl)-5-fluorouracil (FT-207) in the postoperative adjuvant chemotherapy of gastric cancer. Delivery of a fat-emulsified agent to the lymph
URI https://www.ncbi.nlm.nih.gov/pubmed/3080217
https://www.proquest.com/docview/76691017
Volume 57
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07b9swECbSpgi69B00fXLoYA9MLD5Eyg1a9GV0iZEhBbwZZz4CFYrk2nIB_5f-2N7JMjoVHbpooQhJ1Me773gvxt6kpLX2AZlbyKTQ0jsBQRnhnEo-JFQKYdQ1m7DTqZvNissDdr7PhaGwyr1M7AR1aDydkZ_ZPC8IPu-XPwT1jCLfat9A4xY7VEhkKKDLzv7UCreyr0E5csJoNTtiH_uSo2fkdkUjWssB2tw5qb2hsWN9nhdqPIYyCF_7FRojSGYQ5PKdOh3hy7yVAv5ORDuFNLn_f5_ygN3riSj_sEPOQ3YQ60fs6KJ3tT9mv6aZGEjexhbF0TaguMbVr4bCiFRtmhVOB19WfDC5wi1gh7ysOXJJvqRCHcu4qyfOIXzfIFVvOULjps_12vIm8WugfiGeewLd6pR_jhUFiHRjwBO0It5sqnWZkCFzoPQv3jbdA6ot4u8J-zb5cvXpq-hbOQhPnfJElnub0iJTADoCWcDKhRSRcIEufEJBEsCHqJPxC5UvpLeoRI3HIRkWdP8xu103dXzKuHORWr6DJYdxyCzokYtgQmEKHMr0CXu9X_U5bhXyf0Adm816vl_3E3a8-3Hz5a6ix1xRxnFmn_1z6nN2lxBDYduZecEOE8qI-JLd8T_bcr161QEQr9PLi99_peL1
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=N1-%282+tetrahydrofuryl%29-5-fluorouracil+%28FT-207%29+in+the+postoperative+adjuvant+chemotherapy+of+gastric+cancer.+Delivery+of+a+fat-emulsified+agent+to+the+lymph&rft.jtitle=Cancer&rft.au=Hanaue%2C+H&rft.au=Kurosawa%2C+T&rft.au=Kitano%2C+Y&rft.au=Miyakawa%2C+S&rft.date=1986-02-15&rft.issn=0008-543X&rft.volume=57&rft.issue=4&rft.spage=693&rft_id=info:doi/10.1002%2F1097-0142%2819860215%2957%3A4%3C693%3A%3Aaid-cncr2820570402%3E3.0.co%3B2-a&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-543X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-543X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-543X&client=summon